Form 8-K - Current report:
SEC Accession No. 0001104659-24-106310
Filing Date
2024-10-04
Accepted
2024-10-04 17:00:14
Documents
13
Period of Report
2024-10-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2425632d1_8k.htm   iXBRL 8-K 26305
  Complete submission text file 0001104659-24-106310.txt   199692

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA wrby-20241001.xsd EX-101.SCH 3024
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE wrby-20241001_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wrby-20241001_pre.xml EX-101.PRE 22365
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2425632d1_8k_htm.xml XML 3683
Mailing Address 233 SPRING STREET 6TH FLOOR EAST NEW YORK NY 10013
Business Address 233 SPRING STREET 6TH FLOOR EAST NEW YORK NY 10013 (646) 847-7215
Warby Parker Inc. (Filer) CIK: 0001504776 (see all company filings)

EIN.: 800423634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40825 | Film No.: 241355512
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)